Linked Life Data

18165518

Source:http://linkedlifedata.com/resource/pubmed/id/18165518

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
6
pubmed:dateCreated
2007-12-31
pubmed:abstractText
We report the results of clinical studies carried out at six sites in Madagascar, between January and October 2006. The aims were (i) to update our knowledge of the burden of Plasmodium malariae infection and (ii) to assess the therapeutic efficacy of chloroquine for uncomplicated quartan malaria. Our findings confirm that P. malariae is the third leading cause of malaria, accounting for 1.1% of all malarial infections. They also demonstrate that chloroquine-currently recommended for the home management of presumed malaria in children under the age of five years and commonly used by adults-remains highly effective in patients with uncomplicated P. malariae infection.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
AIM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Dec
pubmed:issn
0002-9637
pubmed:author
pubmed:issnType
Print
pubmed:volume
77
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1039-42
pubmed:meshHeading
pubmed:year
2007
pubmed:articleTitle
Short report: prevalence and chloroquine sensitivity of Plasmodium malariae in Madagascar.
pubmed:affiliation
Parasitology and Tropical Medicine, University Lyon 1, Lyon, France.
pubmed:publicationType
Journal Article, Clinical Trial, Research Support, Non-U.S. Gov't